Smad7 protects against chronic aristolochic acid nephropathy in mice

Oncotarget

Volumn 6, Issue 14, 2015, Pages 11930-11944

  Dai, Xiao Yu ^a,b   Zhou, Li ^a,b   Huang, Xiao Ru ^a   Fu, Ping ^b   Lan, Hui Yao ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b SICHUAN UNIVERSITY   (China)

Author keywords

Chronic aristolochic acid nephropathy; Renal fibrosis; Renal inflammation; Smad7

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; ARISTOLOCHIC ACID; CREATININE; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; SMAD3 PROTEIN; SMAD7 PROTEIN; TRANSCRIPTION FACTOR RELA; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; ARISTOLOCHIC ACID I; HERBACEOUS AGENT; SMAD7 PROTEIN, MOUSE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHRONIC ARISTOLOCHIC ACID NEPHROPATHY; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DISEASE MODEL; DISEASE SEVERITY; GENE OVEREXPRESSION; GENE TRANSFER; KIDNEY DISEASE; KIDNEY FIBROSIS; KNOCKOUT MOUSE; MALE; MOUSE; NEPHRITIS; NONHUMAN; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RENAL PROTECTION; URINARY EXCRETION; ANIMAL; CHEMICALLY INDUCED; METABOLISM; PATHOLOGY; REAL TIME POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ANIMALS; ARISTOLOCHIC ACIDS; BLOTTING, WESTERN; DISEASE MODELS, ANIMAL; DRUGS, CHINESE HERBAL; GENE TRANSFER TECHNIQUES; KIDNEY DISEASES; MALE; MICE; MICE, KNOCKOUT; REAL-TIME POLYMERASE CHAIN REACTION; SMAD7 PROTEIN;

EID: 84931438789     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.3718     Document Type: Article

References (30)

1. Vanhaelen M, Vanhaelen-Fastre R, But P and Vanherweghem JL. Identification of aristolochic acid in Chinese herbs. Lancet. 1994; 343:174.
2. Gillerot G, Jadoul M, Arlt VM, van Ypersele De Strihou C, Schmeiser HH, But PP, Bieler CA and Cosyns JP. Aristolochic acid nephropathy in a Chinese patient: time to abandon the term "Chinese herbs nephropathy"?. Am J Kidney Dis. 2001; 38:E26.
3. Vanherweghem JL, Depierreux M, Tielemans C, Abramowicz D, Dratwa M, Jadoul M, Richard C, Vandervelde D, Verbeelen D, Vanhaelen-Fastre R and et al. Rapidly progressive interstitial renal fibrosis in young women: association with slimming regimen including Chinese herbs. Lancet. 1993; 341:387-391.
4. Grollman AP, Shibutani S, Moriya M, Miller F, Wu L, Moll U, Suzuki N, Fernandes A, Rosenquist T, Medverec Z, Jakovina K, Brdar B, Slade N, Turesky RJ, Goodenough AK, Rieger R, et al. Aristolochic acid and the etiology of endemic (Balkan) nephropathy. Proc Natl Acad Sci USA. 2007; 104:12129-12134.
5. Chang CH, Wang YM, Yang AH and Chiang SS. Rapidly progressive interstitial renal fibrosis associated with Chinese herbal medications. Am J Nephrol. 2001; 21:441-448.
6. Tanaka A, Nishida R, Maeda K, Sugawara A and Kuwahara T. Chinese herb nephropathy in Japan presents adultonset Fanconi syndrome: could different components of aristolochic acids cause a different type of Chinese herb nephropathy?. Clin Nephrol. 2000; 53:301-306.
7. Debelle FD, Vanherweghem JL and Nortier JL. Aristolochic acid nephropathy: a worldwide problem. Kidney Int. 2008; 74:158-169.
8. Yang CS, Lin CH, Chang SH and Hsu HC. Rapidly progressive fibrosing interstitial nephritis associated with Chinese herbal drugs. Am J Kidney Dis. 2000; 35:313-318.
9. Debelle FD, Nortier JL, De Prez EG, Garbar CH, Vienne AR, Salmon IJ, Deschodt-Lanckman MM and Vanherweghem JL. Aristolochic acids induce chronic renal failure with interstitial fibrosis in salt-depleted rats. J Am Soc Nephrol. 2002; 13:431-436.
10. Lan HY, Chung AC. TGF-β/Smad signaling in kidney disease. Semin Nephrol. 2012; 32:236-243.
11. Zhou L, Fu P, Huang XR, Liu F, Chung AC, Lai KN and Lan HY. Mechanism of chronic aristolochic acid nephropathy: role of Smad3. Am J Physiol Renal Physiol. 2010; 298:F1006-1017.
12. Kavsak P, Rasmussen RK, Causing CG, Bonni S, Zhu H, Thomsen GH and Wrana JL. Smad7 binds to Smurf2 to form an E3 ubiquitin ligase that targets the TGF beta receptor for degradation. Mol Cell. 2000; 6:1365-1375.
13. Lan HY, Mu W, Tomita N, Huang XR, Li JH, Zhu HJ, Morishita R and Johnson RJ. Inhibition of renal fibrosis by gene transfer of inducible Smad7 using ultrasoundmicrobubble system in rat UUO model. J Am Soc Nephrol. 2003; 14:1535-1548.
14. Wang W, Huang XR, Li AG, Liu F, Li JH, Truong LD, Wang XJ and Lan HY. Signaling mechanism of TGF-beta1 in prevention of renal inflammation: role of Smad7. J Am Soc Nephrol. 2005; 16:1371-1383.
15. Hou CC, Wang W, Huang XR, Fu P, Chen TH, Sheikh-Hamad D and Lan HY. Ultrasound-microbubble-mediated gene transfer of inducible Smad7 blocks transforming growth factor-beta signaling and fibrosis in rat remnant kidney. Am J Pathol. 2005; 166:761-771.
16. Ng YY, Hou CC, Wang W, Huang XR and Lan HY. Blockade of NFkappaB activation and renal inflammation by ultrasound-mediated gene transfer of Smad7 in rat remnant kidney. Kidney Int Suppl. 2005:S83-91.
17. Ka SM, Huang XR, Lan HY, Tsai PY, Yang SM, Shui HA and Chen A. Smad7 gene therapy ameliorates an autoimmune crescentic glomerulonephritis in mice. J Am Soc Nephrol. 2007; 18:1777-1788.
18. Huang XR, Chung AC, Zhou L, Wang XJ and Lan HY. Latent TGF-beta1 protects against crescentic glomerulonephritis. J Am Soc Nephrol. 2008; 19:233-242.
19. Chung, AC, Huang, XR, Zhou, L, Heuchel, R, Lai, KN, Lan, HY: Disruption of the Smad7 gene promotes renal fibrosis and inflammation in unilateral ureteral obstruction (UUO) in mice. N Nephrol Dial Transplant. 2009; 24: 1443-1454.
20. Chen HY, Huang XR, Wang W, Li JH, Heuchel RL, Chung AC and Lan HY. The protective role of Smad7 in diabetic kidney disease: mechanism and therapeutic potential. Diabetes. 2011; 60:590-601.
21. Wei LH, Huang XR, Zhang Y, Li YQ, Chen HY, Yan BP, Yu CM and Lan HY. Smad7 inhibits angiotensin II-induced hypertensive cardiac remodelling. Cardiovasc Res. 2013; 99:665-673.
22. Liu GX, Li YQ, Huang XR, Wei L, Chen HY, Shi YJ, Heuchel RL and Lan HY. Disruption of Smad7 promotes ANG II-mediated renal inflammation and fibrosis via Sp1-TGF-beta/Smad3-NF.kappaB-dependent mechanisms in mice. PLoS One. 2013; 8:e53573.
23. Vanherweghem JL, Abramowicz D, Tielemans C and Depierreux M. Effects of steroids on the progression of renal failure in chronic interstitial renal fibrosis: a pilot study in Chinese herbs nephropathy. Am J Kidney Dis. 1996; 27:209-215.
24. Martinez MC, Nortier J, Vereerstraeten P and Vanherweghem JL. Steroid therapy in chronic interstitial renal fibrosis: the case of Chinese-herb nephropathy. Nephrol Dial Transplant. 2002; 17:2033-2034.
25. Pozdzik AA, Salmon IJ, Husson CP, Decaestecker C, Rogier E, Bourgeade MF, Deschodt-Lanckman MM, Vanherweghem JL and Nortier JL. Patterns of interstitial inflammation during the evolution of renal injury in experimental aristolochic acid nephropathy. Nephrol Dial Transplant. 2008; 23:2480-2491.
26. Li R, Rosendahl A, Brodin G, Cheng AM, Ahgren A, Sundquist C, Kulkarni S, Pawson T, Heldin CH and Heuchel RL. Deletion of exon I of SMAD7 in mice results in altered B cell responses. J Immunol. 2006; 176:6777-6784.
27. Lan HY, Mu W, Nikolic-Paterson DJ and Atkins RC. A novel, simple, reliable, and sensitive method for multiple immunoenzyme staining: use of microwave oven heating to block antibody crossreactivity and retrieve antigens. J Histochem Cytochem. 1995; 43:97-102.
28. Meng XM, Huang XR, Chung AC, Qin W, Shao X, Igarashi P, Ju W, Bottinger EP and Lan HY. Smad2 protects against TGF-beta/Smad3-mediated renal fibrosis. J Am Soc Nephrol. 2010; 21:1477-1487.
29. Liu Z, Huang XR and Lan HY. Smad3 mediates ANG IIinduced hypertensive kidney disease in mice. Am J Physiol Renal Physiol. 2012; 302:F986-997.
30. Huang XR, Chung AC, Yang F, Yue W, Deng C, Lau CP, Tse HF and Lan HY. Smad3 mediates cardiac inflammation and fibrosis in angiotensin II-induced hypertensive cardiac remodeling. Hypertension. 2010; 55:1165-1171.